Search This Blog

Thursday, May 30, 2019

Zynerba to Present at FDA CBD Hearing

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Ray Mannion, Zynerba’s Vice President of Manufacturing, will provide a formal presentation during the U.S. Food and Drug Administration’s (FDA) Public Hearing on Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds. As noted in the Federal Register, the public hearing is scheduled from 8:00 a.m. to 6:00 p.m. ET tomorrow, May 31, 2019.
Slides from Mr. Mannion’s presentation, entitled ‘Cannabinoid Manufacturing and Product Quality’, are now available on Zynerba’s corporate website at https://zynerba.com/publications/.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.